Artificial Intelligence Assists Surgeons' Decision Making

  • End date
    Oct 24, 2024
  • participants needed
  • sponsor
    Jichao Qin
Updated on 24 September 2021
total mesorectal excision


This study will evaluate whether artificial intelligence technique reduces the temporary ileostomy rate in patients with rectal cancer who receive anterior resection.


Anastomotic leakage is a serious and life-threatening complication after anterior resection in patients with rectal cancer, and temporary ileostomy was introduced to reduce the serious consequences due to anastomotic leakage. However, whether a temporary ileostomy is applied in the surgery depends on the surgeon's experience, and there are no clinical guidelines to follow. Recently, artificial intelligence has widely been applied in medical field and produced some exciting results, and we have developed a high-performance artificial intelligence model based on 2369 rectal cancer patients, which showed good discrimination of anastomotic leakage and may reduce the temporary ileostomy rate. Hence, this randomized controlled trail will evaluate the artificial intelligence model for guiding surgical decision-making of performing a temporary ileostomy in patients with rectal cancer who receive anterior resection.

Condition rectal carcinoma, Colorectal Cancer, Colon Cancer Screening, Colon cancer; rectal cancer, Rectal Cancer
Treatment Artificial intelligence algorithm
Clinical Study IdentifierNCT04999007
SponsorJichao Qin
Last Modified on24 September 2021


Yes No Not Sure

Inclusion Criteria

Aged older than 18 years and younger than 85 years
Primary rectal adenocarcinoma confirmed by preoperative pathology result
Expected curative resection via total mesorectal excision procedure
American Society of Anesthesiologists (ASA) class I, II, or III
Written informed consent

Exclusion Criteria

Pregnant or breastfeeding women
Severe mental disorder or language communication disorder
Hartmann surgery or colostomy is performed intraoperatively
Interrupted of surgery for more than 30 minutes due to any cause
Malignant tumors with other organs
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note